Dr. Reddy's Labs Files 6-K
Ticker: RDY · Form: 6-K · Filed: Oct 21, 2025 · CIK: 1135951
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
Dr. Reddy's Labs filed a 6-K, confirming its 20-F filing status.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on October 21, 2025, to report its status as a foreign private issuer. The company, headquartered in Hyderabad, India, confirmed it files annual reports under Form 20-F.
Why It Matters
This filing is a routine procedural document for foreign private issuers, indicating compliance with SEC reporting requirements for companies listed in the US but based abroad.
Risk Assessment
Risk Level: low — This is a standard procedural filing for a foreign private issuer and does not contain new financial or operational information.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- 0001575872-25-000627 (other) — Accession Number
- 20251021 (date) — Filing Date
- Hyderabad, India (location) — Company Headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the registrant may be required to disclose or make public pursuant to the laws of its home country or to distribute or make public a press release.
Which annual report form does Dr. Reddy's Laboratories Ltd. file?
Dr. Reddy's Laboratories Ltd. files its annual reports under cover of Form 20-F.
Where is Dr. Reddy's Laboratories Ltd. headquartered?
Dr. Reddy's Laboratories Ltd. is headquartered at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the Commission File Number for Dr. Reddy's Laboratories Ltd.?
The Commission File Number for Dr. Reddy's Laboratories Ltd. is 1-15182.
What is the SIC code for Dr. Reddy's Laboratories Ltd.?
The Standard Industrial Classification (SIC) code for Dr. Reddy's Laboratories Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-10-21 11:52:43
Filing Documents
- rdy0809_6k.htm (6-K) — 50KB
- rdy0809_ex99-1.htm (EX-99.1) — 22KB
- rdy0809_ex99-1img01.jpg (GRAPHIC) — 11KB
- rdy0809_ex99-1img02.jpg (GRAPHIC) — 9KB
- 0001575872-25-000627.txt ( ) — 100KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: October 21, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3